YSB (HKSE:09885) Growth Rank : 0 (As of Apr. 15, 2025)

View and export this data going back to 2023. Start your Free Trial

What is YSB Growth Rank?

YSB has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

YSB Growth Rank Related Terms

Thank you for viewing the detailed overview of YSB's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

B1S:Germany

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
H Capital V, L.p.	2101 Beneficial owner
Tmf (cayman) Ltd.	2301 Trustee
Tiger Global Private Investment Partners Xi, L.p.	2101 Beneficial owner
Tiger Global Pip Performance Xi, L.p.	2201 Interest of corporation controlled by you
Tiger Global Management, Llc	2102 Investment manager
Shleifer Scott	2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd.	2201 Interest of corporation controlled by you
Coleman Iii Charles	2201 Interest of corporation controlled by you
Miyt Worldwide Limited	2201 Interest of corporation controlled by you
Miyt Holdings Limited	2101 Beneficial owner
Internet Fund V Pte. Ltd.	2306 Nominee for another person
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.	2101 Beneficial owner

YSB Headlines

No Headlines